Welcome to our dedicated page for Humana news (Ticker: HUM), a resource for investors and traders seeking the latest updates and insights on Humana stock.
Humana Inc. (HUM) is a leading health insurance provider specializing in government-sponsored healthcare programs and integrated wellness solutions. This dedicated news hub provides investors and industry professionals with timely updates on corporate developments, financial performance, and strategic initiatives shaping the healthcare sector.
Access authoritative information through verified press releases covering earnings announcements, Medicare Advantage plan expansions, Medicaid service updates, and partnerships in primary care innovation. Track regulatory filings related to prescription drug plans and pharmacy benefit management services critical to HUM's operations.
Key updates include insights into value-based care models, military health program (TRICARE) enhancements, and advancements in at-home healthcare services. All content is sourced directly from company communications to ensure accuracy for financial analysis and market trend evaluation.
Bookmark this page for streamlined access to HUM's latest operational milestones and healthcare industry leadership updates. Check regularly for objective reporting on developments impacting one of America's largest managed care organizations.
Humana (NYSE: HUM) has announced new value-based care partnerships with Vori Health and HOPCo, complementing its existing collaboration with TailorCare, to enhance care for Medicare Advantage members with musculoskeletal conditions.
The expanded program offers comprehensive care coordination through specialized teams that integrate with primary care clinicians. Vori Health's services will be available nationwide for Group Medicare Advantage members, while HOPCo will serve individual members in Arizona. TailorCare's services, currently available in Atlanta, will expand to Dallas in November 2025 and Denver in January 2026.
These partnerships aim to improve healthcare delivery and outcomes through patient-centered, holistic care approaches, particularly significant as musculoskeletal conditions affect nearly 50% of Americans.
Humana's (NYSE: HUM) philanthropic arm, The Humana Foundation, has announced 80 new scholarship recipients for the 2025 academic year. The scholarships provide up to $3,000 annually, renewable for up to three years, with a potential total award of $12,000 per student.
Selected from 653 applicants, the program supports children of Humana employees pursuing postsecondary education. The foundation has expanded eligibility to include vocational and technical schools, alongside traditional colleges. Additionally, 169 students renewed their scholarships from 2024. Since 2001, the foundation has awarded over $15.7 million to more than 1,700 students.
Humana (NYSE: HUM) has achieved two significant workplace recognitions in 2025: its fourth consecutive Great Place To Work Certification™ and second consecutive placement on PEOPLE® Companies that Care list. The company received strong employee endorsement with 81% of employees rating Humana as a great place to work, significantly above the 57% U.S. company average.
Key initiatives highlighted include the inaugural Humana Community Day, enhanced Military-Connected Hiring Strategy, and expansion of CenterWell healthcare services. The company is planning its second nationwide employee day of service for September 4, 2025, demonstrating continued commitment to community engagement and positive workplace culture.
[ "81% of employees rate Humana as a great place to work, significantly exceeding the 57% U.S. average", "Fourth consecutive Great Place To Work Certification achievement", "Second consecutive recognition on PEOPLE Companies that Care list", "Expansion of CenterWell healthcare services indicating business growth" ]Humana (NYSE: HUM) has announced a quarterly cash dividend of $0.885 per share to be paid on October 31, 2025. Stockholders of record as of the close of business on September 26, 2025 will be eligible for this dividend payment.
The company, which operates through Humana insurance services and CenterWell health care services, continues its commitment to delivering healthcare services to Medicare, Medicaid, families, individuals, military personnel, and communities.
Humana (NYSE: HUM) has released new research demonstrating the effectiveness of value-based care for Medicare Advantage patients with heart failure. The study found that patients treated by value-based care clinicians were 28% more likely to receive full quadruple therapy, the gold standard treatment for heart failure.
According to Dr. Kate Goodrich, Humana's Chief Medical Officer, the value-based care model promotes coordinated healthcare delivery through collaboration between primary care physicians, specialists, and care teams. The research shows that patients under this model experience better medical management and chronic disease care compared to traditional fee-for-service approaches.
The findings are particularly significant as heart failure is projected to affect 11.4 million Americans by 2050, with these patients requiring more frequent hospitalizations and emergency department visits.
Humana Inc. (NYSE: HUM) announced the expansion of its annual Humana Community Day, scheduled for September 4, 2025. Building on last year's success in Louisville, where 6,000 employees contributed over 10,000 volunteer hours, the initiative will now extend to Ft. Lauderdale, San Antonio, Tampa, and the Arlington/Washington, D.C. area.
The company, which along with the Humana Foundation contributes approximately $51 million annually in volunteer hours, employee donations, and foundation grants, will engage thousands of employees in various service projects. Activities include assembling meal kits, supporting military families, and partnering with local nonprofits focused on health equity and social connection.
Humana (NYSE: HUM) and DrFirst have announced a strategic partnership to enhance care for patients with chronic conditions like diabetes and cardiovascular disease. The initiative's first phase focuses on increasing statin therapy adoption among eligible patients, aligning with CMS quality metrics.
The program leverages DrFirst's prescription orchestration platform, enabling real-time clinical collaboration between healthcare stakeholders. Providers can receive and act on prescription recommendations with a single click, streamlining the workflow process. The platform is integrated with over 270 EHR systems, facilitating rapid implementation across various care settings.
This collaboration extends the companies' decade-long partnership, which previously introduced the first real-time prescription benefit tool in 2015.
Humana (NYSE:HUM) reported Q2 2025 financial results with GAAP EPS of $4.51 and Adjusted EPS of $6.27. The company raised its full-year 2025 guidance, with Adjusted EPS now expected at approximately $17.00, up from $16.25, and increased revenue guidance to at least $128 billion.
The Insurance segment reported a benefit ratio of 89.9%, aligning with expectations. The company revised its individual Medicare Advantage membership outlook, now projecting a decline of up to 500,000 members, an improvement from the previous estimate of 550,000. CenterWell Primary Care showed strong performance, with anticipated FY 2025 net patient growth of 50,000 to 70,000, exceeding previous expectations.
Humana (NYSE:HUM) announced significant changes to streamline its prior authorization requirements, aiming to reduce administrative burdens and improve patient care access. By January 1, 2026, the company will eliminate approximately one-third of prior authorizations for outpatient services and commit to providing decisions within one business day on 95% of complete electronic prior authorization requests.
Key initiatives include removing authorization requirements for specific diagnostic services, implementing a new gold card program for high-performing providers, and enhancing transparency through public reporting of prior authorization metrics. The company will also advance interoperability efforts and supports the bipartisan Improving Seniors' Timely Access to Care Act.
Humana (NYSE: HUM) has announced a groundbreaking integration with Epic's MyChart platform, becoming the first health insurer to directly embed health plan information into patients' MyChart accounts. This innovative feature will allow Humana Medicare Advantage members to access their insurance details, benefits, and resources in the same interface they use to manage their healthcare.
The integration affects over 3 million Humana members already using MyChart and will provide centralized access to coverage information, deductibles, out-of-pocket costs, digital ID cards, and direct links to health plan resources through a simple account linking process. Members will also have single sign-on access to MyHumana.com and important services like the 24/7 Nurse Advice Line.